How telemedicine platforms, virtual prescriptions, and automated billing created new opportunities for large-scale healthcare fraud
WASHINGTON, DC, December 2, 2025
When telemedicine exploded during and after the COVID-19 pandemic, it was hailed as a breakthrough in access and convenience. Patients could see clinicians from their living rooms, prescriptions could be issued in minutes, and automated billing systems enabled providers to scale services across state and national borders.
Hidden inside that transformation was something else. The same technologies that allowed legitimate virtual care to flourish also gave fraud architects new tools to exploit Medicare and other public health systems at an unprecedented scale. Virtual doctor visits became a script on a screen. Prescriptions turned into digital signatures triggered by call center workflows. Automated billing platforms submitted claims in volumes that would have been impossible in a paper world.
By 2025, telemedicine and related remote-care schemes had become central to some of the most significant health care fraud cases on record. In successive national takedowns, U.S. authorities charged dozens of defendants in schemes that allegedly generated more than a billion dollars in fraudulent telemedicine, genetic testing, and durable medical equipment claims in a single enforcement wave, building on earlier operations such as 2019’s Operation Brace Yourself and Operation Double Helix.
This investigation examines how the “digital doctor” model was abused, how virtual platforms and automated billing turned local scams into global enterprises, what recent case studies reveal about enforcement, and how advisory firms, including Amicus International Consulting, are operating in an environment where health care, technology, and cross-border financial crime are now tightly linked.
Telemedicine’s boom, and the vulnerabilities it exposed
Telemedicine did not begin with the pandemic, but COVID-19 accelerated its adoption. Emergency policy changes expanded reimbursement for remote visits and relaxed some licensing rules, allowing doctors to treat patients across broader geographies. At the same time, technology firms rushed to build platforms that could manage scheduling, video connections, electronic prescribing, and billing in one place.
For legitimate providers and patients, the advantages are clear. Remote consultations reduce travel burdens, fill gaps in underserved areas, and allow flexible follow-up care. For fraud architects, the shift offered something else: a scalable way to generate billable encounters without the physical constraints of in-person practice.
Several structural features of virtual care made it attractive for abuse:
• Distance and volume. A single practitioner could conduct a very high number of short virtual visits in a day, especially if call center staff pre-populate patient data and templated clinical notes.
• Fragmented accountability. Telemarketing firms, telemedicine platforms, ordering clinicians, and suppliers could be separate legal entities, making responsibility harder to untangle.
• Automated routing. Digital workflows could match patients with whichever clinician was available, turning prescribing into a production line rather than a traditional doctor-patient relationship.
• Instantaneous billing. Once a visit and prescription were logged, claims could be generated and transmitted automatically through billing interfaces to Medicare and other payers.
In this environment, dozens of companies emerged offering “turnkey” telehealth and remote ordering services to pharmacies, labs, and durable medical equipment suppliers. Regulators later warned that some of these intermediaries were not true telehealth providers at all, but marketing engines designed to manufacture prescriptions for high-reimbursed items with minimal clinical review.
Case Study 1: The brace boom and the call center doctor
The most visible early example of the digital doctor scam model came from the orthopedic brace sector. In 2019, U.S. authorities announced Operation Brace Yourself, a nationwide takedown targeting an international telemarketing network that used call centers to sell back braces, knees, wrists, and other braces to Medicare beneficiaries.
According to enforcement and industry analyses, call centers controlled by C-suite executives and marketers aggressively promoted “free” or low-cost braces to seniors, collecting Medicare numbers and health information over the phone. Telemedicine companies affiliated with the scheme then routed these beneficiaries to physicians who performed brief, often perfunctory, “virtual” consultations. Prescriptions followed quickly. Durable medical equipment companies, many of them under common control, billed Medicare for large numbers of braces regardless of medical necessity.
The scheme did not simply cost the program money. A later analysis of the operation noted that the 2019 takedown led to an estimated cost avoidance of more than 1.9 billion dollars in the amount Medicare paid for orthotic braces in the 20 months after the enforcement action, a measure of how inflated spending had become while the operation was active.
The architecture of the scam was strikingly modern:
• International call centers ran scripts and captured data.
• Telemedicine providers signed orders after minimal contact.
• Automated billing systems sent high-volume claims to Medicare.
• Money flowed back through management companies, “marketing fees,” and offshore accounts.
Operation Brace Yourself became a template for later telehealth enforcement, and it also produced one of the most prominent fugitives in the health care fraud arena. Herbert “Herb” Kimble, a California telemarketing executive, pleaded guilty in 2019 for his role in the brace and telemarketing scheme. After years of cooperation, he failed to appear for sentencing in October 2024 and is now listed by federal health authorities as a fugitive believed to be living in the Philippines, a vivid example of how digital care can intersect with global flight.
Case Study 2: COVID-era virtual testing and the genetic lab boom
During the pandemic, emergency telehealth waivers were intended to keep patients away from crowded clinics while maintaining access to care. Fraudsters saw an opening.
Enforcement actions and advisory reports in 2022 and 2023 describe schemes in which telemarketing or online lead generation companies recruited Medicare beneficiaries with offers of “free” COVID-19 tests, cancer screening, or cardiac genetic panels. Telemedicine providers, often paid on a volume basis, conducted brief phone or video interactions and ordered large panels of tests that were not medically necessary. Labs then billed Medicare at high rates.
In some cases, labs allegedly paid kickbacks to telemedicine companies for referrals, bundling COVID-19 tests with cardiovascular or cancer genetic tests that produced higher reimbursement. Enforcement summaries describe:
• Physicians who signed large numbers of orders without reviewing complete medical histories.
• Remote “consultations” that lasted only a few minutes and followed script-like formats.
• Labs that relied almost entirely on telehealth-generated orders and paid marketing or consulting fees that bore little resemblance to fair market value.
A special fraud alert issued by federal health inspectors in 2022 warned providers about suspect telemedicine arrangements in which companies promised steady streams of reimbursable orders in exchange for access to physician signatures, a clear signal that regulators had identified the digital doctor model as a systemic risk.
Case Study 3: The 2025 national takedown and the “Operation Gold Rush” model
The most dramatic illustration of how technology magnified health care fraud came in June 2025, when U.S. authorities announced a national health care fraud takedown charging 324 defendants in schemes involving more than 14.6 billion dollars in alleged fraudulent claims.
Telemedicine played a central role. According to official releases and subsequent analysis, forty-nine defendants were charged in connection with over 1.17 billion dollars in alleged telemedicine and genetic testing fraud. Transnational criminal organizations allegedly acquired U.S. medical supply companies, used stolen identities of more than a million beneficiaries, and pushed automated claims for urinary catheters and other items that were never ordered or delivered, a cluster of cases referred to as Operation Gold Rush.
Automated billing platforms were the engine. Once virtual encounters or fabricated orders were logged, claims could be sent to Medicare contractors at scale. When enforcement finally intervened, authorities seized more than 245 million dollars in cash, luxury vehicles, real estate, and cryptocurrency. Still, the alleged intended losses underscored how far digital workflows had outpaced traditional oversight.
The mechanics of the digital doctor scam
Across these and other cases, certain patterns recur, regardless of the specific product or test involved.
1. Lead generation and scripting
Telemarketing firms, online ads, and data brokers identify potential patients, often focusing on seniors and people with chronic conditions. Scripts emphasize “no cost” offers, pre-approved benefits, or limited-time health checks.
2. Virtual intake and templated histories
Call center staff collect basic information, sometimes filling in medical histories that emphasize conditions likely to justify specific tests or devices. These details are entered into electronic forms that feed telemedicine platforms.
3. High-velocity virtual consultations
Telemedicine providers, sometimes working for multiple companies, log in to review pre-populated charts. Encounters are brief and scripted. Doctors may receive flat fees per encounter or per signed order, a structure that regulators later characterized as an unlawful inducement when combined with medically unnecessary care.
4. Automated prescribing and ordering
Electronic health record and e-prescribing systems allow orders to be generated with a few clicks. For certain items, such as durable medical equipment or lab tests, physicians rarely see the end product or the billing that follows.
5. Automated billing and revenue routing
Billing software submits claims directly to Medicare and other payers. Once reimbursements hit provider accounts, funds are quickly transferred to management companies, marketing firms, or offshore entities that provide plausible invoices for “services” but function as conduits for profit distribution.
6. Data exhaust and eventual detection
The same digital systems that enable abuse also create trails. Enforcement agencies can analyze claims data, prescribing patterns, and network linkages. Over time, outlier behavior stands out, especially when combined with complaints from beneficiaries or whistleblowers.
Regulatory and enforcement response
National enforcement strategies have evolved alongside the technology. Health care fraud units now use large-scale data analytics to identify providers and entities whose billing patterns deviate sharply from peers. Reviews of 2024 and 2025 enforcement actions show heavy emphasis on telemedicine and lab testing schemes, with authorities explicitly framing telehealth fraud as a continuing priority.
Key elements of the response include:
• Fraud alerts and guidance. Regulators issue special alerts warning providers about suspect telemedicine arrangements, especially models in which companies offer physicians compensation tied to the volume of orders rather than clinical need.
• Strike forces and data fusion. Dedicated strike forces combine prosecutors, health investigators, and data scientists who access integrated claims data to spot emerging schemes.
• Parallel financial investigations. Health care fraud charges are paired with money laundering and asset forfeiture efforts, reflecting recognition that digital billing scams feed complex financial networks.
• Global coordination. International partners are engaged earlier, especially when telemarketing call centers, foreign shell companies, or cross-border payment processors are involved.
For legitimate telehealth providers, these enforcement trends create both pressure and clarity. Virtual care is no longer a lightly regulated frontier. It is a core focus of national fraud policy.
Global dimensions, call centers, and offshore nodes
Although Medicare is a U.S. program, the digital doctor scam is transnational. Call centers in other countries have played central roles in recruiting patients, and foreign nationals have been charged in several schemes involving telemedicine and durable medical equipment.
Offshore elements appear in multiple ways:
• Call centers that handle outbound marketing and inbound patient responses.
• Software development firms that host or manage telehealth platforms and billing systems.
• Shell companies that nominally own U.S. suppliers or receive “consulting” payments.
• Financial institutions in other jurisdictions that receive and redistribute profits.
When authorities dismantle a scheme, they must work through foreign police, regulators, and financial intelligence units to trace assets and identify individuals behind foreign entities. In the 2025 takedown, for example, transnational criminal organizations were alleged to have submitted more than 12 billion dollars in fraudulent claims, underscoring just how global some operations had become.
Emerging legal and compliance expectations for telehealth
As enforcement actions accumulate, they shape what courts, regulators, and payers expect from telehealth providers and their partners. Several themes are emerging.
• Medical necessity must remain central. Courts and regulators are increasingly skeptical of high-volume telehealth operations that depend on standardized scripts and uniform ordering patterns. Individualized clinical judgment and thorough documentation are key.
• Compensation structures are under scrutiny. Payment arrangements that link clinician income directly to the number of tests ordered or devices prescribed are being challenged as prohibited kickbacks, especially when combined with marketing-driven patient recruitment.
• Vendor due diligence is non-negotiable. Providers are expected to understand who their telemedicine, marketing, and billing partners are and how those partners operate. Pleading ignorance when third-party call centers or platforms drive questionable orders is becoming less viable.
• Data and privacy compliance matters. Telehealth relies on sensitive personal and medical data. Breaches, misuse of patient information, or improper sharing with marketers can create separate enforcement risks in addition to fraud concerns.
Advisory firms and the role of Amicus International Consulting
In this landscape, advisory firms that understand both cross-border compliance and the mechanics of digital health care are playing a growing role.
Amicus International Consulting provides professional services to clients whose lives, businesses, and investments intersect with public health systems, digital platforms, and multiple jurisdictions. For clients involved in telehealth, diagnostics, or device supply, the firm’s work sits firmly within a framework of legal compliance and transparency, not exploitation of gaps.
Advisory engagements may include:
• Mapping where a client’s virtual care or remote diagnostics model touches public payers such as Medicare, and identifying pressure points that enforcement agencies are likely to scrutinize.
• Reviewing relationships with telemarketing, lead generation, and telemedicine vendors to ensure that compensation structures, referral patterns, and documentation standards are consistent with fraud and abuse laws.
• Evaluating corporate structures and cross-border elements in telehealth ventures so that ownership, control, and revenue flows are transparent and defensible under evolving beneficial ownership and anti-money laundering rules.
• Coordinating with external counsel, forensic specialists, and compliance officers when internal reviews reveal that a business line or legacy partner may have engaged in practices that resemble those seen in enforcement actions, helping clients document remedial steps and cooperation with authorities.
• Monitoring regulatory and enforcement trends in key markets, translating complex guidance and case developments into practical checks for clients that operate or invest across borders.
The objective is to help legitimate actors avoid any resemblance to the digital doctor scam, recognizing that in an era of significant national takedowns and high-profile fugitives, regulators are alert to structures that echo past abuses, even when intent is different.
The path forward, technology and trust
Telemedicine and automated billing are not going away. For many patients, especially in rural or underserved communities, virtual care is the only practical way to access specialists. For health systems, digital tools remain essential for managing chronic disease, mental health, and post-acute care.
The question for 2026 and beyond is not whether technology will define care, but whether trust can keep up. National takedowns, fugitives, and billion-dollar fraud figures have exposed the vulnerabilities of a system that adopted digital workflows faster than it built corresponding controls. Enforcement agencies have responded with data analytics, cross-border coordination, and increasingly aggressive prosecutions.
What remains is the more complex work of aligning incentives. As long as business models reward volume without sufficient regard for clinical value, the digital doctor scam will remain tempting for those willing to push the limits. As long as telehealth platforms, marketing companies, and automated billing services can be assembled in opaque chains, public payers will struggle to distinguish legitimate innovation from organized exploitation.
The early years of telemedicine fraud have established a clear record: technology can turbocharge abuse, but it also leaves a detailed trail. The brace schemes, virtual testing operations, and transnational telehealth networks of the last decade have given investigators, auditors, and policymakers a playbook for what to watch for. How effectively those lessons are applied will determine whether the next chapter of digital health is defined by trust and access, or by an arms race between new scams and the systems built to detect them.
Contact Information
Phone: +1 (604) 200-5402
Signal: 604-353-4942
Telegram: 604-353-4942
Email: info@amicusint.ca
Website: www.amicusint.ca
